Xeraya Capital

Xeraya Capital is a Malaysian venture capital and private equity firm focused on global life sciences investments. It funds innovations across medical technologies, pharmaceutical biotechnology, biorenewables, and agritech. The firm catalyzes advancements addressing unmet healthcare needs and promoting global sustainability, integrating worldwide scope with local value creation.

The firm launched its specialized life sciences investment strategy in 2008, identifying early sector potential. Fares Zahir, CEO since 2012, was central, supported by founding team members Aditya Puri and Norazli Mohamad Nor. Puri offered deep life sciences and technology financing experience; Mohamad Nor, expertise in technology investment. This collective background shaped Xeraya's direction.

Xeraya Capital backs innovative life sciences ventures globally, providing capital and strategic guidance. Its mission supports enterprises enhancing human well-being and advancing global sustainability. By fostering scientific breakthroughs, the firm cultivates a resilient ecosystem for future progress, ensuring investments yield enduring positive impact.